TRT and fertility: what the caption gets right and glosses over

What did @alphaclubsupps actually say?

The creator's core claim is reasonable on its face: exogenous testosterone suppresses natural testosterone and sperm production, but conception is still possible for some men on TRT, and fertility support options exist. They name HCG and enclomiphene as the two best interventions, briefly mention kisspeptin peptides, and tell viewers not to let fertility fears stop them from starting TRT.

That last line is where things get shaky. Framing TRT as a "journey which may just change your life" while downplaying fertility risk in a 60-second clip is the kind of casual optimism that can lead men to make irreversible short-term decisions. The claim that "loads of guys" conceive without any intervention is anecdotal and does real work here, softening a well-documented suppression effect that the medical literature takes seriously.

Does the science back this up?

Partially, but with important caveats the video glosses over. Exogenous testosterone reliably suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing LH and FSH, which drives down intratesticular testosterone and sperm production. The suppression is not trivial.

A widely cited review by Grimes et al. (2005, Lancet) on testosterone as a male contraceptive found that azoospermia or severe oligospermia developed in the majority of men on exogenous testosterone, though rates varied by ethnicity and baseline sperm count. Recovery of spermatogenesis after stopping TRT can take six months to over two years, and in some men it does not fully recover (Liu et al., 2006, Journal of Clinical Endocrinology and Metabolism). The idea that the fertility impact is "massively overblown" is not well supported by the reproductive endocrinology literature. It is a real, well-documented effect, not a myth.

That said, co-administration of HCG to maintain intratesticular testosterone and preserve spermatogenesis does have clinical support. Hsieh et al. (2013, Journal of Urology) found that HCG co-treatment largely preserved sperm production in men on exogenous testosterone. That part of the video is on solid ground.

What did they get wrong (or right)?

They got the mechanism right: exogenous testosterone does suppress the natural system, and they said so clearly. Credit for that. HCG as a co-treatment is well supported, and naming it as a primary tool is accurate clinical guidance. Enclomiphene, a selective estrogen receptor modulator, also has reasonable evidence for stimulating endogenous LH and FSH in men, making it a legitimate option, particularly for men who want to preserve or restore fertility without going off testosterone entirely.

Where the video goes wrong is in framing the suppression as something that is "massively overblown." The data does not support that characterization. Azoospermia rates on exogenous testosterone are high enough that multiple testosterone-based male contraceptive trials used this suppression as the mechanism of action. Telling men not to let fertility fears stop them from starting TRT, without emphasizing that baseline sperm banking is a practical, low-cost protective step, is an omission that matters. On kisspeptin, the creator correctly notes that data is limited, which is accurate. It should not be treated as an established fertility-preservation tool.

What should you actually know?

If fertility matters to you now or in the next few years, the practical steps are straightforward and the video does not cover them adequately. Sperm banking before starting TRT is inexpensive relative to fertility treatments and gives you options regardless of how your body responds. This should be the first recommendation anyone gives, and it was not mentioned here.

HCG co-administration is the most evidence-backed approach for preserving spermatogenesis during TRT. Enclomiphene is a reasonable alternative or adjunct, particularly for men who prefer to avoid injectable HCG. Both require a prescribing clinician who understands reproductive endocrinology, not just hormone optimization. Recovery of fertility after stopping TRT is not guaranteed and the timeline is unpredictable. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) reported that while most men recovered sperm production within 6 to 18 months after discontinuation, a subset did not recover to baseline. Age, duration of TRT use, and baseline fertility status all affect outcomes. Anyone making decisions based on what "loads of guys" have experienced is working with the wrong dataset.